Brainstorm Cell Therapeutics Inc. ( BCLI) - Stock Earnings
BCLI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -2.1 million USD | — USD |
| 2025Q4 | -2.4 million USD | 703000 USD |
| 2026Q1 | -2.1 million USD | 178000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BCLI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -17.2 million USD | — USD |
| 2024 | 11.6 million USD | 849000 USD |
| 2025 | -10.3 million USD | 703000 USD |
| 2026 Est. | — | — |
BCLI
Price: $0.86
52 week price:
Earnings Per Share: -0.85 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 566900
Ebitda: -2.4 millionMarket Capitalization: 8.7 million